Clinical Trials Directory

Trials / Unknown

UnknownNCT02277808

Which Apparatus for Inhaled Pentamidine?

Which Apparatus for Inhaled Pentamidine? A Comparison of Drug Delivery to the Lung Between Two Nebulizers: The Respirgard II and the Isoneb.

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The reference nebulizer used for pentamidine nebulization is currently the Respirgard II ®, disposable pneumatic nebulizer. Other nebulizers are on the market and appear to have comparable properties and better availability to the hospital. Several studies remark that all nebulizers with comparable properties could be used for the nebulization.The aim of our work will be to evaluate and compare the pulmonary deposition between the reference nebulizer Respirgard II ®, and one of these nebulizers available on the market, the Isoneb ®. We will measure and compare these data's for each of the nebulizers via nebulization Amikacine and urinary dosage.

Conditions

Interventions

TypeNameDescription
DRUG500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%)
DEVICERespirgard II
DEVICEIsoneb®

Timeline

Start date
2013-12-01
Primary completion
2014-10-01
First posted
2014-10-29
Last updated
2014-10-29

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02277808. Inclusion in this directory is not an endorsement.